Use of a glucocorticoid composition for the treatment of severe and uncontrolled asthma
一种糖皮质激素、组合物的技术,应用在糖皮质激素组合物治疗重度和不受控哮喘领域,能够解决不良副作用、阻碍患者有效治疗等问题
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0126]This example describes the therapy of the invention using a fluticasone composition and an AKITA device adapted to practice the invention. The study was conducted at the Davos Pulmonary Clinic. More than 100 patients with severe asthma who have been chronically maintained on oral corticosteroids are now treated with once-daily inhaled high-dose fluticasone (2000 microgram fluticasone filler dose) using the AKITA system. Patients are selected based on their need for OCS and based on poor symptom control. All patients had been previously treated with an inhaled corticosteroid / beta agonist combination using a metered dose inhaler and a dry powder inhaler and oral steroids at a mean of 22.9 mg / day prednisolone or equivalent. None of the patients had adequately controlled asthma symptoms and adequate lung function as measured by FEV1.
[0127] The treatment period was approximately 1 to 9 weeks, with an average of 3 weeks, inhaled fluticasone 2000 micrograms once daily in a...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com